Literature DB >> 7093928

Computed tomography in the evaluation and treatment of endometrial carcinoma.

K Hasumi, M Matsuzawa, H F Chen, M Takahashi, M Sakura.   

Abstract

Since patients with endometrial carcinoma tend to be elderly, diabetic and hypertensive, individualization of treatment is very important. The therapy for each patient with endometrial carcinoma should be individualized and determined by the stage and factors predisposing to extrauterine spread of the tumor. Such risk factors include the grade of the tumor and depth of myometrial invasion. Unfortunately, staging based on pelvic examination is inaccurate in endometrial carcinoma and the depth of myometrial invasion cannot be assessed preoperatively. In order to assess its uses in the staging and treatment planning of endometrial cancer, CT was performed in 28 previously untreated patients with endometrial cancer. Twenty patients subsequently underwent surgery and the CT findings were correlated with the surgical and pathologic findings. CT proved to be useful in determining the depth of myometrial invasion and whether cervical involvement is present or not. Such information provided by CT helps to plan treatment more adequately and accurately for the individual patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093928     DOI: 10.1002/1097-0142(19820901)50:5<904::aid-cncr2820500517>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Local staging of endometrial carcinoma: role of multidetector CT.

Authors:  A C Tsili; C Tsampoulas; N Dalkalitsis; D Stefanou; E Paraskevaidis; S C Efremidis
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

2.  Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.

Authors:  Megan Buechel; Anindya Dey; Shailendra Kumar Dhar Dwivedi; Aleia Crim; Kai Ding; Roy Zhang; Priyabrata Mukherjee; Kathleen N Moore; Liangxian Cao; Arthur Branstrom; Marla Weetall; John Baird; Resham Bhattacharya
Journal:  Mol Cancer Ther       Date:  2018-07-19       Impact factor: 6.261

3.  Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.

Authors:  Stella Capriglione; Francesco Plotti; Andrea Miranda; Roberto Ricciardi; Giuseppe Scaletta; Alessia Aloisi; Federica Guzzo; Roberto Montera; Roberto Angioli
Journal:  Tumour Biol       Date:  2015-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.